González Arbeláez Luisa Fernanda, Ciocci Pardo Alejandro, Fantinelli Juliana Catalina, Mosca Susana María
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina.
Universidad Nacional de La Plata, Argentina.
Exp Mol Pathol. 2016 Apr;100(2):266-75. doi: 10.1016/j.yexmp.2016.01.009. Epub 2016 Feb 1.
Our aim was to assess the action of cyclosporine-A (CsA) against reperfusion injury in spontaneously hypertensive rats (SHR) compared to the effects of ischemic pre- (IP) and postconditioning (IPC), examining the role played by PKCε. Isolated hearts were submitted to the following protocols: IC: 45 min global ischemia (GI) and 1h reperfusion (R); IP: a cycle of 5 min GI and 10 min of R prior to 45 min-GI; and IPC: three cycles of 30s-GI/30s-R at the start of R. Other hearts of the IC, IP and IPC groups received CsA (mitochondrial permeability transition pore inhibitor) or chelerythrine (Che, non-selective PKC inhibitor). Infarct size (IS) was assessed. TBARS and reduced glutathione (GSH) content - as parameters of oxidative damage, the expression of P-Akt, P-GSK-3β, P-PKCε and cytochrome c (Cyc) release - as an index of mitochondrial permeability and the response of isolated mitochondria to Ca(2+) were also measured. IS similarly decreased in preconditioned, postconditioned and CsA treated heart showing the highest values in the combinations IP+CsA and IPC+CsA. TBARS decreased and GSH was partially preserved after all interventions. The content of P-Akt, P-GSK-3β and P-PKCε increased in cytosol and decreased in mitochondria after IP and IPC. In CsA treated hearts these enzymes increased in both fractions reaching the highest values. Cyc release was attenuated and the response of mitochondria to Ca(2+) was improved by the interventions. The beneficial effects of IP and IPC were annulled when PKC was inhibited with Che. A PKCε/VDAC association was also detected. These data show that, in SHR, the CsA treatment mimicked and reinforced the cardioprotective action afforded by IP and IPC in which PKCε-mediated attenuation of mitochondrial permeability appears as the main mechanism involved.
我们的目的是评估环孢素A(CsA)对自发性高血压大鼠(SHR)再灌注损伤的作用,并与缺血预处理(IP)和后处理(IPC)的效果进行比较,同时研究蛋白激酶Cε(PKCε)所起的作用。将离体心脏按照以下方案进行处理:IC组:45分钟全心缺血(GI)和1小时再灌注(R);IP组:在45分钟全心缺血之前进行一个5分钟全心缺血和10分钟再灌注的循环;IPC组:在再灌注开始时进行三个30秒全心缺血/30秒再灌注的循环。IC组、IP组和IPC组的其他心脏分别给予CsA(线粒体通透性转换孔抑制剂)或白屈菜红碱(Che,非选择性PKC抑制剂)。评估梗死面积(IS)。还测量了丙二醛(TBARS)和还原型谷胱甘肽(GSH)含量(作为氧化损伤参数)、磷酸化Akt(P-Akt)、磷酸化糖原合成酶激酶-3β(P-GSK-3β)、磷酸化PKCε的表达以及细胞色素c(Cyc)释放(作为线粒体通透性指标),以及离体线粒体对钙离子(Ca(2+))的反应。预处理、后处理和CsA处理的心脏中梗死面积均有类似程度的减小,其中IP + CsA和IPC + CsA组合中的梗死面积最大。所有干预后TBARS含量降低,GSH部分得以保留。IP和IPC后,细胞质中P-Akt、P-GSK-3β和P-PKCε含量增加,线粒体中含量降低。在CsA处理的心脏中,这两种组分中的这些酶含量均增加并达到最高值。干预可减弱Cyc释放并改善线粒体对Ca(2+)的反应。当用Che抑制PKC时,IP和IPC的有益作用消失。还检测到PKCε与电压依赖性阴离子通道(VDAC)的关联。这些数据表明,在SHR中,CsA处理模拟并增强了IP和IPC提供的心脏保护作用,其中PKCε介导的线粒体通透性减弱似乎是主要作用机制。